Boehringer raises hope of diabetic macular ischaemia therapy May 6, 2024 AutoBot News 0 Boehringer Ingelheim says it may have found the first therapy for diabetic macular ischaemia (DMI), a common and irreversible complication of the eye in people with diabetes.